regulatory
confidence high
sentiment negative
materiality 0.85
Minerva Neurosciences, Inc. (NERV): Nasdaq/NYSE listing notice — Minerva Neurosciences receives Nasdaq delisting determination; intends to request hearing
Minerva Neurosciences, Inc.
- Received second Nasdaq notice on May 31 for continued non-compliance with minimum Market Value of Listed Securities ($35M).
- Failed to regain compliance by May 30, 2023 deadline; Nasdaq staff determined to delist.
- Company intends to request a hearing before Nasdaq Hearings Panel to stay delisting action.
- Panel may grant extension up to November 27, 2023; no assurance of regaining compliance.